Please login to the form below

Not currently logged in
Email:
Password:

Iptacopan

This page shows the latest Iptacopan news and features for those working in and with pharma, biotech and healthcare.

Novartis’ iptacopan scores positive results in rare blood disorder PNH

Novartis’ iptacopan scores positive results in rare blood disorder PNH

New treatment options are needed, and these positive results further strengthen the profile of iptacopan as a promising oral monotherapy. ... At the highest dose of 200mg twice daily, a 23% reduction in proteinuria was predicted with iptacopan treatment

Latest news

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
foxandcat.online

some pressure is helpful but too much of the wrong sort quickly takes its toll. we help creatove agenices manage...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...